This is the fifth Blog Post in a series examining Duchenne Muscular Dystrophy (DMD) in the rare disease and orphan drug space. This Blog Post discusses the EspeRare Foundation and how the organization is using repositioning or repurposing of an old drug to benefit DMD.
Drug repositioning or drug repurposing (DR) is applying existing drugs to new indications or diseases. DR is increasing in importance to many drug development and pharmaceutical companies.